-PharmaMar has submitted a Phase II clinical trial of Aplidin for the treatment of COVID-19 to the Spanish Medicines Agency

    Press/Media

    Period3 Apr 2020

    Media coverage

    1

    Media coverage

    • Title-PharmaMar has submitted a Phase II clinical trial of Aplidin for the treatment of COVID-19 to the Spanish Medicines Agency
      Media name/outletENP Newswire
      CountryUnited Kingdom
      Date3/04/20
      PersonsI. Sola